<産業資料/調査レポートの題名> 2022年6月19日

体外膜酸素化装置の世界市場:治療法別、地域別


◆英文タイトル:Extracorporeal Membrane Oxygenation Machines Market by Modality and Geography - Forecast and Analysis 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market sizing 2019
• Market size and forecast 2019-2024
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: CUSTOMER LANDSCAPE
PART 07: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 08: MARKET SEGMENTATION BY MODALITY
• Market segmentation by modality
• Comparison by modality
• Veno-venous and arterio-venous – Market size and forecast 2019-2024
• Veno-arterial – Market size and forecast 2019-2024
• Market opportunity by modality
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Mergers and acquisitions
• Business strategies in the market
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALung Technologies Inc.
• Eurosets Srl
• Fresenius Medical Care AG & Co. KGaA
• Getinge AB
• LivaNova Plc
• Medtronic Plc
• MicroPort Scientific Corp.
• NIPRO Corp.
• OriGen Biomedical Inc.
• Terumo Corp.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare equipment market
Exhibit 02: Segments of global healthcare equipment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Customer landscape
Exhibit 19: Market share by geography 2019-2024 (%)
Exhibit 20: Geographic comparison
Exhibit 21: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 22: North America – Year-over-year growth 2020-2024 (%)
Exhibit 23: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 24: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 25: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 26: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 27: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 28: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 29: Key leading countries
Exhibit 30: Market opportunity
Exhibit 31: Modality – Market share 2019-2024 (%)
Exhibit 32: Comparison by modality
Exhibit 33: Veno-venous and arterio-venous – Market size and forecast 2019-2024 ($ millions)
Exhibit 34: Veno-venous and arterio-venous – Year-over-year growth 2020-2024 (%)
Exhibit 35: Veno-arterial – Market size and forecast 2019-2024 ($ millions)
Exhibit 36: Veno-arterial – Year-over-year growth 2020-2024 (%)
Exhibit 37: Market opportunity by modality
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Product recalls
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Business strategies and their market impact analysis
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: ALung Technologies Inc. – Vendor overview
Exhibit 48: ALung Technologies Inc. – Product segments
Exhibit 49: ALung Technologies Inc. – Key offerings
Exhibit 50: ALung Technologies Inc. – Key customers
Exhibit 51: Eurosets Srl – Vendor overview
Exhibit 52: Eurosets Srl – Product segments
Exhibit 53: Eurosets Srl – Organizational developments
Exhibit 54: Eurosets Srl – Key offerings
Exhibit 55: Eurosets Srl – Key customers
Exhibit 56: Fresenius Medical Care AG & Co. KGaA – Vendor overview
Exhibit 57: Fresenius Medical Care AG & Co. KGaA – Business segments
Exhibit 58: Fresenius Medical Care AG & Co. KGaA – Organizational developments
Exhibit 59: Fresenius Medical Care AG & Co. KGaA – Geographic focus
Exhibit 60: Fresenius Medical Care AG & Co. KGaA – Segment focus
Exhibit 61: Fresenius Medical Care AG & Co. KGaA – Key offerings
Exhibit 62: Fresenius Medical Care AG & Co. KGaA – Key customers
Exhibit 63: Getinge AB – Vendor overview
Exhibit 64: Getinge AB – Business segments
Exhibit 65: Getinge AB – Organizational developments
Exhibit 66: Getinge AB – Geographic focus
Exhibit 67: Getinge AB – Segment focus
Exhibit 68: Getinge AB – Key offerings
Exhibit 69: Getinge AB – Key customers
Exhibit 70: LivaNova Plc – Vendor overview
Exhibit 71: LivaNova Plc – Business segments
Exhibit 72: LivaNova Plc – Organizational developments
Exhibit 73: LivaNova Plc – Geographic focus
Exhibit 74: LivaNova Plc – Segment focus
Exhibit 75: LivaNova Plc – Key offerings
Exhibit 76: LivaNova Plc – Key customers
Exhibit 77: Medtronic Plc – Vendor overview
Exhibit 78: Medtronic Plc – Business segments
Exhibit 79: Medtronic Plc – Organizational developments
Exhibit 80: Medtronic Plc – Geographic focus
Exhibit 81: Medtronic Plc – Segment focus
Exhibit 82: Medtronic Plc – Key offerings
Exhibit 83: Medtronic Plc – Key customers
Exhibit 84: MicroPort Scientific Corp. – Vendor overview
Exhibit 85: MicroPort Scientific Corp. – Business segments
Exhibit 86: MicroPort Scientific Corp. – Organizational developments
Exhibit 87: MicroPort Scientific Corp. – Geographic focus
Exhibit 88: MicroPort Scientific Corp. – Segment focus
Exhibit 89: MicroPort Scientific Corp. – Key offerings
Exhibit 90: MicroPort Scientific Corp. – Key customers
Exhibit 91: NIPRO Corp. – Vendor overview
Exhibit 92: NIPRO Corp. – Product segments
Exhibit 93: NIPRO Corp. – Geographic focus
Exhibit 94: NIPRO Corp. – Segment focus
Exhibit 95: NIPRO Corp. – Key offerings
Exhibit 96: NIPRO Corp. – Key customers
Exhibit 97: OriGen Biomedical Inc. – Vendor overview
Exhibit 98: OriGen Biomedical Inc. – Product segments
Exhibit 99: OriGen Biomedical Inc. – Organizational developments
Exhibit 100: OriGen Biomedical Inc. – Key offerings
Exhibit 101: OriGen Biomedical Inc. – Key customers
Exhibit 102: Terumo Corp. – Vendor overview
Exhibit 103: Terumo Corp. – Business segments
Exhibit 104: Terumo Corp. – Organizational developments
Exhibit 105: Terumo Corp. – Geographic focus
Exhibit 106: Terumo Corp. – Segment focus
Exhibit 107: Terumo Corp. – Key offerings
Exhibit 108: Terumo Corp. – Key customers
Exhibit 109: Validation techniques employed for market sizing
Exhibit 110: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark